the vision to heal

The potential to simulate natural healing


Noveome is advancing its ST266 biologic, a first-of-its-kind, multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing. We believe this novel biologic holds significant clinical potential across a range of important underserved conditions in ophthalmology, neurology, dermatology—and beyond.

exciting science

Learn more about ST266 and its unique and powerful healing potential.

advancing pipeline

Explore our portfolio covering a range of important ophthalmic indications.

rewarding careers

Join a passionate, diverse team dedicated to making a positive difference in patients’ lives.

making news

December 12, 2023

Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its…

August 17, 2023

Noveome Biotherapeutics, Inc. Completes First Close of $40 Million Series…

November 16, 2022

Noveome Biotherapeutics, Inc. Announces New Appointments to Board of Directors